Lusutrombopag, LUTRODX, Lusutrombopag, 3mg Manufacturer: Laos Daxiong Pharmaceutical Introduction: 3mg*7 tablets

Lusutrombopag is a drug used to treat thrombocytopenia, particularly in certain patients with chronic liver disease. It is a thrombopoietin receptor agonist that increases platelet count by promoting platelet production.

The following is an overview of some key information about Lusutrombopag :

1. Name of drug

• Generic Name : Lusutrombopag
• Product Name :

2. Indications

Lusutrombopag is primarily used to treat:

• Thrombocytopenia in patients with chronic liver disease : It is indicated for patients with thrombocytopenia due to chronic liver disease (such as cirrhosis) and who need to increase their platelet count when undergoing medical procedures (such as invasive treatments).

3. Usage and Dosage

Lusutrombopag is usually given by mouth as follows:

• Adult dosage : The recommended dose is 40 mg , once a day, taken orally for 7 consecutive days. The duration of treatment depends on the individual condition and usually needs to be adjusted under the guidance of a doctor.

Key points when using:

• How to take : Lusutrombopag should be taken after meals to reduce irritation to the gastrointestinal tract.
• Dosage adjustment : If your platelet count reaches your target level after treatment, your doctor may adjust your medication schedule.

4. Adverse reactions

Common adverse reactions include:

• Headache
• fatigue
• Joint pain
• nausea
• rash

Serious adverse reactions may include:

• Thrombosis : Due to increased platelet count, there may be a risk of thrombosis, so regular monitoring of platelet counts is required during use.
• Liver function abnormalities : Particularly in patients with liver disease, liver function may be affected and regular monitoring of liver function is required.

5. Contraindications

Lusutrombopag is contraindicated in patients with:

• Patients with hypersensitivity to lusutrombopag or its components.
• Active thrombotic disease : Use with caution in patients with a history of thrombosis.
• This medicine should be avoided in patients with severe liver damage (such as liver failure).

6. Notes

• Risk of thrombosis : When using this drug, the platelet count needs to be monitored regularly to avoid the risk of thrombosis caused by excessive increase in platelets.
• Liver function monitoring : Patients with chronic liver disease should undergo regular liver function tests during use to ensure the safety of drug use.
• Pregnancy and breast-feeding : Pregnant and breast-feeding women generally avoid using this drug because its safety has not been adequately evaluated.

7. Drug Interactions

Lusutrombopag may interact with certain medications, especially those that affect blood clotting or platelet production. When using lusutrombopag, patients should tell their doctor about other medications they are taking, including prescription and over-the-counter medicines and supplements.